
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, focused on developing TCR-based therapeutics for cancer and autoimmune diseases. Utilizing…

T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, focused on developing TCR-based therapeutics for cancer and autoimmune diseases. Utilizing…
Headquarters: Granta Park, Cambridge, United Kingdom
Focus: TCR-based therapeutics for oncology and autoimmune disease
Platform: Proprietary OpTiMus® transgenic discovery platform
Founded: 2022
Recent financing: Series A; additional equity injection announced Nov 13, 2025
Improving targeted T cell engagement for treatment of cancer and autoimmune diseases
2022
Biotechnology
$59,000,000
Series A announced in Nov 2023 with a syndicate including Sofinnova Partners, Cambridge Innovation Capital, Cambridge Enterprise, F-Prime, Sanofi Ventures and Digitalis Ventures.
$32,000,000
Additional equity injection announced Nov 13, 2025 adding Tencent and Business Growth Fund to the investor base.
“Company backed by a syndicate including Sofinnova Partners, Cambridge Innovation Capital, Cambridge Enterprise, Digitalis Ventures, F-Prime, Sanofi Ventures, Tencent, Business Growth Fund and University of Cambridge Enterprise”
| Company |
|---|
Job Title: Research Associate/Senior Research Associate
Department: Protein Sciences
Reports To: Head of Protein Sciences
Contract Type: Full time
About The Company T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases.
Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development.
T-Therapeutics was founded in 2022, and we are at the very beginning of our journey to develop transformative T cell derived medicines. To realise our ambition, we are currently building facilities, recruiting staff, and establishing our research operations.
Summary We are seeking a highly motivated and skilled Research Associate/Senior Research Associate to join our Protein Sciences team. The ideal candidate will have a background in protein purification, biophysical characterisation, and analysis. Experience working with novel format biologics and/or with analytical equipment such as a HPLC would be desirable. The successful candidate will contribute to the purification, and characterization of recombinant proteins to support our drug discovery and development programmes. This role offers an excellent opportunity to work within a fast-paced, cutting-edge research environment and contribute to the advancement of novel therapeutics.
Key Responsibilities
Qualifications
Company Benefits T-Therapeutics offers employees a wide range of benefits. These include a generous pension contribution, life insurance, health insurance and a health cash plan. Employees will be offered share options in the company, as well as 28 days’ holiday each year (not including standard bank holidays).
You will have the opportunity to contribute to innovative drug development, in an open environment, able to learn all aspects of drug development. T-Therapeutics is also committed to enabling staff to grow professionally in a variety of ways as well as providing the chance to develop cutting-edge technologies.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week